APA (7th ed.) Citation

JC, Y., ES, K., TH, P., YS, L., SJ, H., JY, H., . . . SH, C. (2026). Efficacy and Safety of Telmisartan 20 mg/S-Amlodipine 2.5 mg versus Telmisartan 40 mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial. Drug design, development and therapy, 20, 587488. https://doi.org/10.2147/DDDT.S587488

Chicago Style (17th ed.) Citation

JC, Youn, et al. "Efficacy and Safety of Telmisartan 20 Mg/S-Amlodipine 2.5 Mg Versus Telmisartan 40 Mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 Mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial." Drug Design, Development and Therapy 20 (2026): 587488. https://doi.org/10.2147/DDDT.S587488.

MLA (9th ed.) Citation

JC, Youn, et al. "Efficacy and Safety of Telmisartan 20 Mg/S-Amlodipine 2.5 Mg Versus Telmisartan 40 Mg in Patients with Hypertension, Inadequately Controlled on Telmisartan 20 Mg Monotherapy: A Randomized, Double-Blind, Multicenter, Phase 3 Trial." Drug Design, Development and Therapy, vol. 20, 2026, p. 587488, https://doi.org/10.2147/DDDT.S587488.